CytoDyn (CYDY) Cash from Investing Activities (2010 - 2022)
CytoDyn (CYDY) posted Cash from Investing Activities of -$17000.0 for Q1 2022, down 240.0% on a QoQ basis from -$5000.0 in Q4 2021, and up 26.09% year-over-year from -$13482.8 in Q1 2021.
CytoDyn (CYDY) Cash from Investing Activities (2010 - 2022) Analysis & Trends
CytoDyn's Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$17000.0 for Q1 2022.
- Quarterly Cash from Investing Activities rose 26.09% year-over-year to -$17000.0 in Q1 2022, while the trailing twelve-month figure through Feb 2022 was -$52000.0 (up 49.51% YoY) and the FY2021 annual result came in at -$122000.0, down 197.56% from the prior year.
- Cash from Investing Activities was -$17000.0 for Q1 2022 at CytoDyn, down from -$5000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$920.0 in Q1 2019 and bottomed at -$59000.0 in Q3 2020.
- A 5-year average of -$17000.0 and a median of -$13000.0 in 2019 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 92.83% in 2020, while the deepest fall reached 2508.7% in 2020.
- CytoDyn's Cash from Investing Activities stood at -$2262.0 in 2018, then sank by 297.88% to -$9000.0 in 2019, then tumbled by 100.0% to -$18000.0 in 2020, then surged by 72.22% to -$5000.0 in 2021, then plunged by 240.0% to -$17000.0 in 2022.
- Business Quant data shows CYDY's Cash from Investing Activities at -$17000.0 in Q1 2022, -$5000.0 in Q4 2021, and -$8000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | -25.54 Mn |
| 10 | CytoDyn | 261.29 Mn | 261.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2022 | -17,000.00 |
| Feb 28, 2022 | -17,000.00 |
| Nov 30, 2021 | -5,000.00 |
| Nov 30, 2021 | -5,000.00 |
| Aug 31, 2021 | -8,000.00 |
| Aug 31, 2021 | -8,000.00 |
| May 31, 2021 | -22,000.00 |
| May 31, 2021 | -22,000.00 |
| Feb 28, 2021 | -23,000.00 |
| Feb 28, 2021 | -23,000.00 |
| Nov 30, 2020 | -18,000.00 |
| Nov 30, 2020 | -18,000.00 |
| Aug 31, 2020 | -59,000.00 |
| Aug 31, 2020 | -59,000.00 |
| May 31, 2020 | -3,000.00 |
| May 31, 2020 | -3,000.00 |
| Feb 29, 2020 | -24,000.00 |
| Feb 29, 2020 | -24,000.00 |
| Nov 30, 2019 | -9,000.00 |
| Nov 30, 2019 | -9,000.00 |